|
Real-time Estimate
Cboe BZX
22:32:46 08/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 23.62 USD | -3.69% |
|
-6.82% | -1.34% |
| 09-22 | Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy | CI |
| 09-16 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.69% | -6.82% | -19.10% | -22.31% | -1.34% | +56.21% | +43.27% | -25.32% | - | 3.12B | |
| -3.19% | -3.19% | +5.71% | +36.94% | +78.73% | +44.60% | +87.98% | +6.02% | - | 74.68B | |
| -15.86% | -16.16% | -18.50% | -11.78% | -1.56% | +2.68% | +51.09% | +176.38% | +4,700.00% | 58.7B | |
| -2.39% | +0.50% | +1.33% | -1.68% | +4.76% | +3.41% | +31.33% | -18.54% | +202.09% | 48.36B | |
| -7.43% | -9.76% | -10.38% | -2.10% | +133.26% | +288.52% | +629.45% | +568.79% | - | 43.05B | |
| -0.78% | -1.62% | -1.05% | +25.86% | +13.79% | +27.86% | +28.54% | +5.89% | +221.38% | 42.48B | |
| -4.26% | -2.83% | -0.82% | +15.48% | +14.74% | -0.71% | +101.75% | -4.03% | +985.64% | 41.39B | |
| -2.13% | +1.07% | -3.60% | +0.79% | +4.19% | +7.51% | +50.31% | +2.56% | +139.76% | 31.29B | |
| -2.87% | -4.73% | -6.48% | -1.35% | -3.08% | -13.18% | -15.59% | -62.48% | - | 23.93B | |
| -1.72% | -7.65% | -19.71% | -13.94% | -42.38% | -38.03% | +309.14% | +252.35% | +567.20% | 22.22B | |
| -5.27% | +1.86% | +8.82% | +24.52% | +16.23% | +12.19% | -3.32% | -15.04% | +105.41% | 22.24B | |
| -1.44% | -0.16% | +1.06% | +12.24% | +6.32% | +12.45% | +140.83% | +216.28% | +1,873.98% | 16.87B | |
| -0.83% | -1.65% | -9.81% | -11.33% | +182.04% | +139.28% | +356.14% | +1,992.52% | +684.56% | 15.67B | |
| -1.07% | +1.56% | +6.32% | +12.88% | +21.31% | +21.51% | +45.47% | -28.45% | +83.09% | 14.87B | |
| -1.44% | -0.90% | -16.60% | -18.73% | - | - | - | - | - | 15B | |
| -3.10% | +2.01% | +4.22% | +30.65% | +46.68% | +68.67% | +51.55% | -28.49% | +250.50% | 14.34B | |
| +2.48% | +3.54% | +4.02% | +6.91% | +36.87% | +55.25% | +179.15% | +177.47% | +375.73% | 14.48B | |
| -3.59% | +3.51% | -0.03% | +10.10% | -1.23% | -25.99% | +934.43% | +246.89% | +45.41% | 14.36B | |
| -3.17% | -10.73% | +6.22% | +19.24% | +15.65% | -33.86% | - | - | - | 12.69B | |
| -0.14% | +0.69% | +2.92% | -1.51% | -10.57% | -12.61% | -31.69% | -38.56% | +106.23% | 12.66B | |
| Average | -3.08% | -1.52% | -3.27% | +5.54% | +27.07% | +32.41% | +166.10% | +190.24% | +738.64% | 27.12B | |
| Weighted average by Cap. | -4.22% | -1.28% | -3.22% | +8.56% | +32.14% | +38.46% | +149.05% | +151.39% | +1,107.71% |
- Stock Market
- Stocks
- RCUS Stock
- Sector Arcus Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
